The Arcturus subvariant stems from the Omicron strain of Covid-19 and is known as XBB.1.16 since it descends from the recombinant variant XBB, which combines two sublineages of Omicron BA.2.
The first recorded death of someone who has the new Arcturus strain of Covid-19 has been revealed. This variant has been described as the most transmissible yet and has a symptom which has not ...
A 'zombie star' could be resurrected on Halloween night, experts say. T Coronae Borealis, also known as the 'Blaze Star,' is expected to explode, which will illuminate a dead binary star system.
the MHLW is an important milestone for the saRNA field and the Arcturus/CSL alliance, which has candidates against other variants in phase 3 testing – including the prevailing XBB.1.5 strain ...
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Arcturus Therapeutics ARCT in the last three months. The table below summarizes their recent ...
Neda Safarzadeh, Sr. Director, Head of IR, PR & Marketing, Arcturus Therapeutics Holdings Inc., San Diego, CA, USA, Tel: +1-858-900-2682 Arcturus Therapeutics, based ...
Arcturus Therapeutics Holdings Inc. stock is down 46% since Sept. 2023 coverage; mRNA sector faces headwinds with public skepticism (35% comfortable with technology) and challenges translating ...
Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant ...
The ongoing Phase 1 study, fully funded by BARDA, aims to evaluate the safety and immune responses of the vaccine, reducing financial strain on Arcturus’ other therapeutic programs. Additionally ...
With current treatments and vaccines for H5N1 considered insufficient or poorly matched to circulating strains, Arcturus' sa-mRNA approach could offer a more effective solution. However ...
Collectively, these elements underscore Arcturus Therapeutics’ capacity for innovation and market penetration, justifying the Buy rating. ARCT’s price has also changed moderately for the past ...